There have been few head-to-head studies of disease-modifying drugs for MS. This study used a statistical technique called “network meta-analysis” to address that deficiency.

In a large MS group, cognitive impairment rates were unexpectedly low and few had severe impairment

Relatives of people with MS have more white matter signal abnormalities than matched controls.

A review article suggests that venocentric lesions seen on MRI may be an early marker of MS